Idexx Laboratories (IDXX) Capital Expenditures (2009 - 2026)

Idexx Laboratories has reported Capital Expenditures for 18 years, with the latest figure at $24.6 million in Q2 2026.

• On a quarterly basis, Capital Expenditures fell 27.73% year-over-year to $24.6 million in Q2 2026; TTM through Jun 2026 was $117.2 million, a 3.53% decrease from a year earlier, with the FY2025 full-year figure at $124.7 million, up 3.1% from the prior year.
• Capital Expenditures was $24.6 million for Q2 2026 at Idexx Laboratories, down from $32.0 million in the prior quarter.
• The five-year high for Capital Expenditures was $49.2 million in Q4 2022, with the low at $24.6 million in Q2 2026.
• Average Capital Expenditures over 5 years is $32.5 million, with a median of $31.5 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2023: Capital Expenditures surged 57.9% in 2022, then sank 33.87% in 2023.
• Over 5 years, Capital Expenditures stood at $49.2 million in 2022, then plunged by 33.87% to $32.6 million in 2023, then dropped by 10.14% to $29.3 million in 2024, then rose by 0.61% to $29.4 million in 2025, then dropped by 16.27% to $24.6 million in 2026.
• The last three Capital Expenditures figures came in at $24.6 million (Q2 2026), $32.0 million (Q1 2026), and $29.4 million (Q4 2025), per Business Quant data.